By creating a free Inderes account, you get access to Inderes analysis, you can order the popular morning review and follow companies and discussions that interest you.
Already have an account?
Follow this company like 12801 other investors.
Analyytikko
ORION CORPORATION PRESS RELEASE 30 March 2023 at 9.30 EEST
Orion is building a unique pharmaceutical research ecosystem in Finland – using data and artificial intelligence to shorten the development time of new innovative medicines
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE27 MARCH 2023 at 09.00 EEST
Comparative net sales data for 2022 under Orion's new organisational structure and revised accounting practice as of 1 January 2023
ORION CORPORATION PRESS RELEASE 23 March 2023 at 15:00 EET Orion and Bayer expand clinical development program for darolutamide in prostate cancer
ORION CORPORATION STOCK EXCHANGE RELEASE / OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE22 MARCH 2023 at 17.15 EET
Orion Corporation: Organising meeting of the Board of Directors
In its organising meeting, the Board of Directors of Orion Corporation, which was elected today by the Annual General Meeting of the Shareholders, has elected Hilpi Rautelin as Vice Chair.
The compositions of the Board committees were decided to be as follows:
ORION CORPORATION STOCK EXCHANGE RELEASE / DECISIONS OF GENERAL MEETING22 MARCH 2023 at 16.30 EET
Decisions taken by Orion Corporation’s Annual General Meeting on 22 March 2023
At the Annual General Meeting of Orion Corporation held today, the following decisions were made:
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE21 March 2023 at 17:45 EET
Orion Corporation: Charman of the Nomination Committee changes
ORION CORPORATION PRESS RELEASE 20 March 2023 at 09:00 EET Darolutamide approved for additional prostate cancer indication in China
ORION CORPORATION MANAGERS’ TRANSACTIONS 9 MARCH 2023 at 11.30 EET
Orion Corporation: Managers’ transactions – Kari Jussi Aho
Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2023 at 15.00 EET
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
Orion Corporation: Managers’ transactions – Virve Laitinen
